LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) today announced that David S. Albers, Ph.D., Senior Director, Preclinical Research & Development of Inotek, will present a poster titled “Increased secretion of MMPs contributes to trabodenoson-induced changes in the conventional outflow facility” at the American Glaucoma Society’s 2016 Annual Meeting. The poster presentation will take place on the morning of Friday, March 4th at the Harbor Beach Marriott Resort & Spa in Fort Lauderdale, Florida.
